cbdMD Expands Wellness Portfolio with $30M Twinlab Acquisition — cbdMD, Inc.

Event summary

cbdMD to acquire Twinlab brands (Twinlab, Reserveage, Metabolife, Alvita Tea) via ABC proceeding, subject to court approval.
Deal expected to boost cbdMD's revenue to ~$30M, a 40% increase from standalone TTM revenue.
Acquisition diversifies cbdMD's portfolio into legacy supplements, sports nutrition, and beauty categories.
Transaction aims to reduce cbdMD's revenue concentration in hemp-derived products amid evolving regulations.
Combined entity will span supplements, sports nutrition, longevity, functional wellness, and hemp-derived products.

The big picture

This acquisition marks cbdMD's strategic shift from a CBD-focused company to a broader consumer wellness platform. The deal reflects the industry trend of consolidation in the wellness sector, as companies seek to diversify their portfolios and mitigate regulatory risks. With the addition of Twinlab's established brands, cbdMD aims to serve a wider range of consumer needs, from foundational nutrition to modern wellness solutions.

What we're watching

Integration Challenges: Whether cbdMD can successfully integrate Twinlab's legacy brands while maintaining operational efficiency.
Regulatory Mitigation: The pace at which cbdMD can reduce its hemp revenue concentration amid evolving regulations.
Market Penetration: How cbdMD's marketing and ecommerce resources will drive brand awareness for Twinlab's products.